The four settlements with Juul Labs announced today resolve the personal injury, consumer class action, government entity, and tribal harm cases brought in the national MDL and the JCCP in CaliforniaCo-Lead Counsel for Plaintiffs in the federal multidistrict litigation captioned In re: Juul Labs, Inc., Marketing, Sales Practices and Products Liability
On November 9, 2022, U.S. District Judge Yvonne Gonzalez Rogers of the Northern District of California issued an order naming Lieff Cabraser partner Lexi J. Hazam as Co-Lead Counsel for plaintiffs in the nationwide multidistrict teen/youth social media addiction litigation alleging that social media apps such as Facebook and TikTok cause
The lawsuit challenges Meta/Instagram’s exploitative platform features, which it alleges were developed and honed to take advantage of developmental vulnerabilities in young users’ brains; “We make body image issues worse for one in three teen girls,” notes Instagram’s own internal report. San Francisco—(BUSINESSWIRE)—On September 1, 2022, Lieff Cabraser Heimann & Bernstein, LLP and Protectus Law
Federal court certifies four separate classes in national Juul teen injury, fraud, and RICO litigation that includes Juul Labs Inc. and Altria (formerly Philip Morris Companies, Inc.) as well as various individual corporate defendants June 29, 2022, San Francisco—(BUSINESSWIRE)—On June 29, 2022, plaintiffs in the federal Juul fraudulent advertising and
On June 23, 2022, the U.S. Food and Drug Adminstration (FDA) issued a stunning market denial order mandating that Juul Labs Inc. cease the sale and distribution of all of their currently marketed products in the United States. The extraordinary Order also directs that all Juul products currently on the U.S.
On June 13, 2022, plaintiffs won a series of procedural victories in the kidney and bone injury lawsuit filed against pharma giant Gilead Sciences when California Superior Court Judge Andrew Y.S. Cheng denied three summary judgment motions filed by Gilead seeking to dismiss the litigation. Since the dangers from Gilead’s prescription medications (Truvada® and Atripla®) that
In a case focusing on Bausch & Lomb’s artificial in-eye lenses that can break inside patient’s eyes, causing vision that is equivalent to seeing the world through a kaleidoscope — at best — plaintiffs won a signal victory in the Connecticut Supreme Court when that authority held that the plaintiffs’ injury claims against Bausch &
As reported by the LA Times, the Coastal Laguna Niguel brush fire which destroyed at least 20 homes on May 11, 2022 is being actively investigated for a possible utility cause. Southern California Edison issued a report stating that “our information reflects circuit activity occurring close in time to the reported time of the fire.”
As reported by Law360 (subscription), on May 2, 2022, U.S. District Judge William H. Orrick of the Northern District of California issued an order denying the meaningful portions of the latest wave of defendants’ motions to dismiss claims from a teen’s lawsuit alleging that e-cigarette manufacturer Juul and its part-owner Altria
The World Health Organization and UNICEF have published a new report that summarizes the findings of a multi-national study examining the impact of formula milk marketing on infant feeding decisions and practices. The research study, the largest of its kind to date, draws on the experiences of over 8,000 women and more than 300 health